Hellenic Institute for the Study of Sepsis
2 clinical trials · 2 recruiting · OTHER
Trials by Hellenic Institute for the Study of Sepsis
RECRUITINGNCT06601998
Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.
Pneumonia, which can be acquired in the community (including influenza and COVID-19), is a leading cause of mortality. The risk of severe cardiovascular diseases events (stroke,...
Sponsor: Hellenic Institute for the Study of SepsisEnrolling: 65017 locations
Pneumonia, Community-AcquiredCOVID-19 PneumoniaCardiovascular Diseases
RECRUITINGPhase 3NCT06294600
Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
The primary objective of the REACT randomized clinical trial (RCT) is to optimize the clinical benefit from adjunctive clarithromycin treatment shown in the ACCESS trial and to...
Sponsor: Hellenic Institute for the Study of SepsisEnrolling: 33020 locations
Community-acquired Pneumonia